C07D 233/94
With hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other
Official title: with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members
C07D233/94 (With hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other) appears on 88 US grants and 49 published applications in this corpus.
Search patents in C07D- Granted patents
- 88
- Published applications
- 49
- Assignees
- 46
- Inventors
- 184
- Latest grant
- 8 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 11 | 0 |
| 1978 | 3 | 0 |
| 1979 | 2 | 0 |
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 5 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 5 | 0 |
| 1991 | 3 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 1 |
| 2003 | 1 | 4 |
| 2004 | 2 | 2 |
| 2005 | 2 | 1 |
| 2006 | 2 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 1 | 2 |
| 2010 | 0 | 2 |
| 2011 | 0 | 0 |
| 2012 | 1 | 1 |
| 2013 | 0 | 3 |
| 2014 | 3 | 2 |
| 2015 | 1 | 1 |
| 2016 | 1 | 4 |
| 2017 | 4 | 1 |
| 2018 | 0 | 3 |
| 2019 | 1 | 2 |
| 2020 | 4 | 7 |
| 2021 | 4 | 4 |
| 2022 | 1 | 2 |
| 2023 | 2 | 2 |
| 2024 | 2 | 1 |
| 2025 | 1 | 2 |
By publication year. Applications have been published since 2001.
Recent patents
- Platform drug delivery system utilizing crystal engineering and theanine dissolution8 Apr 2025US 12,268,783 B2Theaprin Pharmaceuticals Inc.
- Deuterated secnidazole for use in the treatment of bacterial vaginosis and methods and uses thereof24 Dec 2024US 12,172,969 B2Evofem Biosciences, Inc.
- Linker containing arylnitro, antibody-drug conjugate containing linker and use of linker15 Oct 2024US 12,115,226 B2Academy of Military Medical Sciences
- Secnidazole for use in the treatment of bacterial vaginosis27 Jun 2023US 11,684,607 B2Lupin Limited
- Secnidazole for use in the treatment of sexually transmitted infection14 Mar 2023US 11,602,522 B2Lupin Limited
- Deuterated secnidazole for use in the treatment of bacterial vaginosis and methods and uses thereof30 Oct 2025US 2025/0333384 A1Evofem Biosciences, Inc.
- Platform drug delivery system utilizing crystal engineering and theanine dissolution17 Jul 2025US 2025/0228778 A1Theaprin Pharmaceuticals Inc.
- Full continuous synthesis device and method for metronidazole15 Aug 2024US 2024/0270696 A1Fudan University
- Deuterated secnidazole for use in the treatment of bacterial vaginosis and methods and uses thereof2 Nov 2023US 2023/0348397 A2Lupin Limited
- Deuterated secnidazole for use in the treatment of bacterial vaginosis and methods and uses thereof30 Mar 2023US 2023/0097494 A1Lupin Limited
Most cited
By later US patents
- 1,3-propane diol esters and ethers and methods for their use in drug delivery162US 6,555,700 B1Scotia Holdings PLC · 2003
- Fatty acid esters as bioactive compounds147US 6,245,811 B1Scotia Holdings PLC · 2001
- Pharmaceutically active compounds72US 5,272,167 ASchering Corporation · 1993
- Pharmaceutically active compounds55US 4,851,423 ASchering Corporation · 1989
- Imidazole compounds and medicinal use thereof42US 7,060,721 B1Fujisawa Pharmaceutical Co., Ltd. · 2006